Dr. Reddy’s Laboratories Ltd is a leading pharmaceutical company based in India, offering expertise in Active Pharmaceutical Ingredients (APIs), generics, biosimilars, custom pharmaceutical services, and differentiated formulations. Q2 FY26 Earnings Summary Consolidated revenue declined 8.73% year on year to ₹461 crore from ₹503 crore (note: the initial data in the query showed a large figure […]
Company Overview: Dr. Reddy’s Laboratories Ltd is a prominent Indian pharmaceutical company offering a broad range of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars, and differentiated formulations. Financial Highlights for Q1 FY26: Revenue: ₹8,572 crore, up 11.38% year-on-year from ₹7,696 crore Total Expenses: ₹6,957 crore, up 15.81% year-on-year […]
Dr. Reddy’s Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddys Laboratories Ltd reported Revenues for Q4FY25 of ₹8,528.00 Crores up from ₹7,114.00 Crore year on year, a rise of […]
Dr. Reddy’s Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddys Laboratories Ltd reported Revenues for Q3FY25 of ₹8,381.00 Crores up from ₹7,237.00 Crore year on year, a rise of […]
Dr. Reddy’s Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddys Laboratories Ltd reported Revenues for Q2FY25 of ₹8,038.00 Crores up from ₹6,903.00 Crore year on year, a rise of […]
Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddy’s Laboratories Ltd reported Revenues for Q1FY25 of ₹7,696.00 Crores up from ₹6,758.00 Crore year on year, a rise of […]
Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddy’s Laboratories Ltd reported Revenues for Q4FY24 of ₹5,105.00 Crores up from ₹4,554.00 Crore year on year, a rise of […]
Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddy’s Laboratories Ltd reported Revenues for Q3FY24 of ₹7,237.00 Crores up from ₹6,790.00 Crore year on year, a rise of […]
Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddys Laboratories Ltd reported Revenues for Q2FY24 of ₹6,903.00 Crores up from ₹6,332.00 Crore year on year, a rise of […]
Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddy’s Laboratories Ltd reported Revenues for Q1FY24 of ₹6,758.00 Crores up from ₹5,233.00 Crore year on year, a rise of […]